Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
With an annual production capacity of 4.7 billion board feet, Interfor is the third largest lumber producer in North America. The company's portfolio is well-diversified geographically, with a strong ...
Albany International Initiates Review of Strategic Alternatives for Structures Assembly Business; Announces Loss Reserve Adjustment for CH-53K Program; Schedules Earnings Release Date Third-Quarter ...
Strong financial position with cash, cash equivalents and short-term investments of $786.5 million as of June 30, 2025 expected to fund projected operations and key clinical milestones through at ...
The words that make up your compliance program documents are critical, there’s no doubt about that. But they will only ever be words on a page if their structure and design are disconnected. Mark ...
A small team is rescuing a “ridiculous amount” of shells from restaurant trash bins and using them to rebuild oyster habitat in Long Island Sound. Credit... Supported by By Kate Selig Photographs and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback